Ranibizumab for treatment of neovascular age-related macular degeneration: a phase I/II multicenter, controlled, multidose study. [electronic resource]
Producer: 20060411Description: 633.e1-4 p. digitalISSN:- 1549-4713
- Aged
- Antibodies, Monoclonal -- administration & dosage
- Antibodies, Monoclonal, Humanized
- Choroidal Neovascularization -- drug therapy
- Cross-Over Studies
- Female
- Fluorescein Angiography
- Follow-Up Studies
- Fundus Oculi
- Humans
- Injections
- Intraocular Pressure
- Macular Degeneration -- complications
- Male
- Ranibizumab
- Retreatment
- Visual Acuity -- physiology
- Vitreous Body
No physical items for this record
Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.